The Distribution of Meningioma in Dr. Hasan Sadikin General Hospital Bandung Period 2010–2013 by Gunadi, Stephanie Victoria et al.
Althea Medical Journal. 2018;5(3)
157
The Distribution of Meningioma in Dr. Hasan Sadikin General Hospital 
Bandung Period 2010–2013 
Stephanie Victoria Gunadi,1 Sri Suryanti,2 Raden Yohana31Bethesda General Hospital Serukam West Kalimantan, Indonesia, 2Department of Anatomical Pathology Faculty of Medicine Universitas Padjadjaran/Dr. Hasan Sadikin General Hospital Bandung, Indonesia, 3Department of Surgery Faculty of Medicine Universitas Padjadjaran/Dr. Hasan Sadikin General Hospital Bandung, Indonesia
Abstract
Background: In neurological diseases, brain tumor is the second leading cause of death after stroke, of which the most common types of brain tumor is meningioma. There are many factors affect the prognosis of meningioma patient, including age, gender, location, and histopathological type of tumor. This study aimed to explore the distribution of meningioma based on age, gender, location of the tumor, and its histopathological type during the period of 2010–2013 in Dr. Hasan Sadikin General Hospital Bandung.
Methods: This study was a quantitative descriptive study and data were collected from medical records of Department of Pathology between January 2010-December 2013. Age, gender, location, and histopathological type of meningioma were acquired. 
Results: There were 277 eligible cases of meningioma with an average number of cases per year were 69 cases. The ratio of men to women was 1:6.4.  Meningioma was most commonly found in the age group 41-50 years (38.9%), and mostly located in convexity (55.96%). The most common histopathological type of meningioma was meningotheliomatous meningioma (70%).
Conclusions: The frequency of meningioma is 6 times higher in women, predominantly around the age of 50 years old. Meningioma is most commonly found in convexity, and meningotheliomatous meningioma is the most common histopathological type. 
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IntroductionMeningioma is an encapsulated tumor in the central nervous system which originates from meningothelial arachnoid cells.1,2 The majority of meningiomas are benign, yet it could be dangerous if the tumor expands and emerging causing an increase of intracranial pressure because of its intracranial location and often leads to headache, nausea, vomit, incoordination, and seizure.3,4 Based on WHO, 
meningioma can be classified into 3 grades, i.e. benign (grade I), atypical (grade II), and anaplastic (grade III).5 Women is twice as likely as men to develop meningioma and its incidence increases with age.6,7  Intracranial meningioma is more common than spinal meningioma.8 In Indonesia9, there are few data about central nervous system tumors, including meningioma. A research in 2009–2013 at RSUD Abdul Moeloek (RSUDAM) and RS. Imanuel 
Bandar Lampung showed 55.7% cases of central nervous system tumors were meningiomas. In 1997–2001, the average of meningioma cases in the Department of Pathology, Faculty of Medicine Universitas Padjadjaran/Dr. Hasan Sadikin General Hospital Bandung is 12 cases per year, and 51 cases per year in 2007–2009.9 
Prognosis of meningioma is influenced by age, gender, location of tumor, and Word Healt Organization (WHO) grading of meningioma 
(Grade I III) which is classified based on type of histopathology.10 Location at the convexity of the brain in this study is aimed at frontal, temporal, parietal, and occipital cortex.11 This study aimed to explore the distribution of meningioma based on age, gender, location, and histopathological type.
MethodsThis was a quantitative, descriptive study with retrospective data collection, conducted at the 
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Department of Pathology, Faculty of Medicine, Universitas Padjadjaran/Dr. Hasan Sadikin General Hospital Bandung in August –October 2014. The total data from 2010 to 2013 of patients with central nervous system tumor who had histopathological examinations at the Department of Pathology was collected. This study had been approved by the Health Research Ethics Committee Faculty of Medicine, Universitas Padjadjaran/Dr. Hasan Sadikin General Hospital Bandung.The inclusion criteria were patients diagnosed with meningioma based on histopathological examination, with a complete medical record of age, gender, the location of the tumor and the type of histopathological diagnosis. Incomplete data was not collected. Data was described and presented in table form.  
ResultsThere were 277 cases of meningioma among Central Nervous system Tumor during the 
Table 1 The distribution of Central Nervous System Tumor and Meningioma in Dr. Hasan 
  Sadikin General Hospital during the period of 2010 –2013
Year
CNS tumor Meningioma
n n %2010 85 15 17.652011 169 84 49.702012 193 92 47.672013 199 86 43.22Total 646 277 42.87Note: CNS, central nervous system tumour
Figure Microscopic Figure of    
 Meningotheliomatous    
 Meningioma12 
grade III meningioma was 5.04%.
DiscussionsThis study has explored the distribution of meningioma in Dr. Hasan Sadikin General Hospital Bandung, during the period 2010–2013. In this study, there is an increase in the incidence rate of meningioma in almost every year, however, the frequency of meningioma is increased in 2011 and decreased until 2013 because of an increased in the incidence of other CNS tumors. The average of meningioma cases was 69 cases per year. This number is higher than the previous study described in 2007 2009 with 51 cases per year. It might occur because people and health providers are 
period of 2010 2013 of which 11 data were excluded due to incomplete medical records. The highest frequency of meningioma in all central nervous system tumors in this study was in 2011 (49.70%), but the highest incidence of meningioma was in 2012 with 92 cases as shown in Table 1. To illlustrate, the 
nicroscopic figure of meningotheliomatous meningioma diagnosed in Departement of 
Pathology was shown in figure 1. In this study, meningioma was commonly found in reproductive age (21–60 years old) and more than 80% of meningioma found in women (Table 2). More than half of all meningioma cases were in convexity and most of all were an intracranial meningioma (tabel 3). Meningotheliomatous meningioma was the most common type with 194 cases (70.03%) 
and followed by fibrous meningioma with 21 cases (7.58%). Chordoid, secretory, and lymphoplasmocyte-rich meningioma were not found in this study. Almost all of the cases were WHO grade I meningioma (90.22%), WHO grade II meningioma was 4.69%, and WHO 
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more concern about health nowadays. People could have better health care because of the development of referring system in Indonesia, therefore meningioma can be detected earlier and its cases in Dr. Hasan Sadikin General Hospital Bandung, as a referring hospital in West Java, might increase every year.13 Meningioma occurred more frequently in females with 240 cases (87%) than in males with 37 cases (13%). This result is similar to study by Shah, et al.6 which showed that 
Table 2 The distribution  of Meningioma Based on Age and Gender
Age Man Woman Total11–20 3 3 621–30 9 12 2131–40 5 86 9141–50 11 97 10851–60 8 36 4461–70 1 4 571–80 - 2 2Total 37 (13.35%) 240 (86.64%) 277 (100%)
Table 3 The Distribution of Meningioma  
  Based on Location
Location Total Percentage (%)Convexity 156 56.32Sphenoid Wing 62 22.38Retroorbital 8 2.89Intraspinal 7 2.53Retro bulbar 6 2.17Olfactory Groove 5 1.81Petroclival 5 1.81Intraorbital 5 1.81CPA 5 1.81Suprasellar 4 1.44Tubercullum 3 1.08Posterior Fossa 3 1.08Sellar Region 3 1.08Extra cranial 2 0.72Calvarial 1 0.36Parasagittal 1 0.36Cerebellum 1 0.36
meningioma occurred predominantly in women with women and men ratio was 2:1.6 This result might be related with hormonal factors as one of the potential risk factors of meningioma such as estrogen, androgen, and progesterone receptor that are increasingly found in meningioma.7 The incidence rate of meningioma is increasing with age.7 In this study, an increase of meningioma cases has been shown at early 20 years old, especially in women, but decreased after age of 50 years. The frequency of meningioma is increased in productive women when the hormone production is high as shown in this study that the highest rate of meningioma cases is in the age group of 41–50 years and the lowest rate is in the age group of 71–80 years. Interestingly, none of the meningioma cases found in the early age group or the eldterly. This may happen because asymptomatic meningioma can be only detected later by the neuroimaging technology such as CT scan and MRI.14 The most common type of meningioma in this study was meningotheliomatous 
meningioma (70.03%), followed by fibrous type (7.58%), and psammomatous type (5.77%), and 90.22% from all cases is categorized as WHO grade I meningioma. This result was similar as the previous study in which WHO grade I meningioma is prevalent in more than 90% of all cases, followed by WHO grade II, and WHO grade III. Furthermore, the prevalence of intracranial meningioma is more common than intraspinal meningioma, 
confirming the study conducted previously.8 Convexity, falx and parasagittal, and sphenoid wing are the most common locations for meningioma as shown in this study.15 The limitation of this study is that low 
meningioma in early years might not reflect the prevalence and incidence. It may be due to 
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Table 4 The Distribution of Meningioma   
   Based on Histopathological Type 
Histopathological 
Type Total PercentageMeningotheliomatous 194 70.03%Fibrous 21 7.58%Transitional 5 1.80%Psammomatous 16 5.77%Angiomatous 9 3.24%Microcystic 4 1.44%Secretory 0 0%Lymphoplasmocyte-rich 0 0%Metaplastic 1 0.36%Atypical 10 3.61%Chordoid 0 0%Clear Cell 3 1.08%Papillary 1 0.36%Rhabdoid 6 2.16%Anaplastic 7 2.52%Total 277 100%Note: *Grade I: Meningotheliomatous, fibrous, transitional, psammomatous, angiomatous, microcystic, secretory, lymphoplasmocyte-rich, metaplastic; Grade II: chordoid, clear cell, atypical; Grade III: Papillary, Rhabdoid, Anaplastic
a lower capacity to diagnose in that period. A better medical record should be implemented. To conclude, meningioma is more common in women and the most common type is meningotheliomatous meningioma with the convexity being the most common location for meningioma. 
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